This company has been marked as potentially delisted and may not be actively trading. Vermillion (VRML) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock VRML vs. TRIB, BMRA, CDIO, VRAX, TNFA, AWH, MYMD, NAVB, IDXX, and LNTHShould you be buying Vermillion stock or one of its competitors? The main competitors of Vermillion include Trinity Biotech (TRIB), Biomerica (BMRA), Cardio Diagnostics (CDIO), Virax Biolabs Group (VRAX), TNF Pharmaceuticals (TNFA), Aspira Women's Health (AWH), MyMD Pharmaceuticals (MYMD), Navidea Biopharmaceuticals (NAVB), IDEXX Laboratories (IDXX), and Lantheus (LNTH). These companies are all part of the "medical" sector. Vermillion vs. Trinity Biotech Biomerica Cardio Diagnostics Virax Biolabs Group TNF Pharmaceuticals Aspira Women's Health MyMD Pharmaceuticals Navidea Biopharmaceuticals IDEXX Laboratories Lantheus Vermillion (NASDAQ:VRML) and Trinity Biotech (NASDAQ:TRIB) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, community ranking, institutional ownership, media sentiment and risk. Does the media refer more to VRML or TRIB? In the previous week, Trinity Biotech had 1 more articles in the media than Vermillion. MarketBeat recorded 1 mentions for Trinity Biotech and 0 mentions for Vermillion. Trinity Biotech's average media sentiment score of 0.88 beat Vermillion's score of 0.00 indicating that Trinity Biotech is being referred to more favorably in the news media. Company Overall Sentiment Vermillion Neutral Trinity Biotech Positive Do insiders and institutionals have more ownership in VRML or TRIB? 18.1% of Vermillion shares are owned by institutional investors. Comparatively, 79.0% of Trinity Biotech shares are owned by institutional investors. 4.4% of Vermillion shares are owned by company insiders. Comparatively, 8.2% of Trinity Biotech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is VRML or TRIB more profitable? Trinity Biotech has a net margin of -34.39% compared to Vermillion's net margin of -307.31%. Trinity Biotech's return on equity of 0.00% beat Vermillion's return on equity.Company Net Margins Return on Equity Return on Assets Vermillion-307.31% -155.25% -103.47% Trinity Biotech -34.39%N/A -21.37% Does the MarketBeat Community believe in VRML or TRIB? Trinity Biotech received 131 more outperform votes than Vermillion when rated by MarketBeat users. Likewise, 69.79% of users gave Trinity Biotech an outperform vote while only 66.67% of users gave Vermillion an outperform vote. CompanyUnderperformOutperformVermillionOutperform Votes20466.67% Underperform Votes10233.33% Trinity BiotechOutperform Votes33569.79% Underperform Votes14530.21% Which has more volatility & risk, VRML or TRIB? Vermillion has a beta of 3.47, meaning that its stock price is 247% more volatile than the S&P 500. Comparatively, Trinity Biotech has a beta of 0.86, meaning that its stock price is 14% less volatile than the S&P 500. Which has better earnings & valuation, VRML or TRIB? Vermillion has higher earnings, but lower revenue than Trinity Biotech. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVermillion$4.54M1.73-$15.24MN/AN/ATrinity Biotech$61.56M0.19-$24.02M-$2.82-0.23 SummaryTrinity Biotech beats Vermillion on 11 of the 14 factors compared between the two stocks. Get Vermillion News Delivered to You Automatically Sign up to receive the latest news and ratings for VRML and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRML vs. The Competition Export to ExcelMetricVermillionDiagnostic Substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.84M$2.70B$5.46B$8.57BDividend YieldN/A0.73%5.26%4.19%P/E Ratio-0.477.8027.1119.93Price / Sales1.7338.48449.23154.99Price / CashN/A15.7538.2534.64Price / Book0.895.896.844.63Net Income-$15.24M-$65.73M$3.23B$247.95M Vermillion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRMLVermillionN/A$0.08-5.2%N/A-96.6%$7.84M$4.54M-0.4743TRIBTrinity Biotech1.6097 of 5 stars$0.69-6.4%N/A-62.6%$12.51M$61.56M-0.31480Upcoming EarningsBMRABiomerica0.9841 of 5 stars$3.11-7.2%N/A-32.2%$7.92M$5.68M-9.1560CDIOCardio Diagnostics2.8365 of 5 stars$3.95-6.8%$60.00+1,419.0%-79.0%$6.87M$19,902.000.001VRAXVirax Biolabs Group3.1634 of 5 stars$1.02+2.0%$3.00+194.1%-3.8%$3.30M$84,872.000.005Positive NewsShort Interest ↓TNFATNF PharmaceuticalsN/A$0.17+7.1%N/AN/A$2.47MN/A-0.036AWHAspira Women's Health1.1166 of 5 stars$0.08-12.5%$5.50+6,607.3%-96.7%$2.44M$9.18M-0.07110High Trading VolumeMYMDMyMD PharmaceuticalsN/A$0.17+7.1%N/A-91.3%$413,000.00N/A0.006High Trading VolumeNAVBNavidea BiopharmaceuticalsN/A$0.00flatN/AN/A$70,000.00$8,126.000.0010IDXXIDEXX Laboratories3.3772 of 5 stars$501.57-0.6%$536.00+6.9%+6.8%$40.34B$3.93B47.0110,800Positive NewsLNTHLantheus4.4793 of 5 stars$73.86-1.2%$132.67+79.6%-6.5%$5.11B$1.54B12.29700Positive NewsInsider Trade Related Companies and Tools Related Companies Trinity Biotech Competitors Biomerica Competitors Cardio Diagnostics Competitors Virax Biolabs Group Competitors TNF Pharmaceuticals Competitors Aspira Women's Health Competitors MyMD Pharmaceuticals Competitors Navidea Biopharmaceuticals Competitors IDEXX Laboratories Competitors Lantheus Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRML) was last updated on 6/4/2025 by MarketBeat.com Staff From Our PartnersAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredJune 23 Could Trigger $40 Trillion ShiftJune 23 Could Trigger Huge Breakthrough In Under-the-Radar Tech On June 23, scientists will quietly gather ...Stansberry Research | SponsoredJunior Explorer Taps Into TSMC’s $165 Billion Chip CorridorThe chip war is moving underground. As the U.S. ramps up semiconductor production to outpace China, an unex...Capital Trends | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump plotting new lockdown?It's listed inside the White House's own documents: Federal Register notice 90 FR 4544 to be exact. And wh...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vermillion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vermillion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRML Stock Free VRML Stock Alerts